ArticleMolecular cancer therapeutics2022

Combination Therapy of Hepatocellular Carcinoma by GPC3-Targeted Bispecific Antibody and Irinotecan is Potent in Suppressing Tumor Growth in Mice.

Xin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.